Before the advent of FAP PET imaging, detection of FAP in the tumor stroma of RCC by immunohistochemistry had been suggested for use as a biomarker for the presence of synchronous metastases and of metastases to the lymph nodes (14). The gene discussed is FAP; the disease is renal cell carcinoma.